ESTA(Establishment Labs Holdings Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $126.68M | $161.70M | $165.15M | $166.03M | $211.08M |
| 毛利润 | $85.40M | $106.59M | $106.98M | $109.53M | $146.31M |
| 营业利润 | −$25.14M | −$39.66M | −$65.03M | −$49.99M | −$39.01M |
| 净利润 | −$41.14M | −$75.21M | −$78.50M | −$84.60M | −$51.06M |
| 经营现金流 | −$27.53M | −$52.17M | −$88.51M | −$58.52M | −$50.89M |
| 自由现金流 | −$29.96M | −$55.02M | −$96.42M | −$64.63M | −$56.94M |
| 摊薄每股收益 | $-1.72 | $-3.08 | $-3.07 | $-3.00 | $-1.72 |